Lamivudine therapy in renal allograft recipients with hepatitis B virus infection

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 35; no. 1; pp. 278 - 279
Main Authors Tsang, W.K, Tong, K.L, Chan, H.W.H
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.02.2003
Elsevier Science
Subjects
Adult
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Antiviral Agents - therapeutic use
Biological and medical sciences
Female
Hepatitis B - drug therapy
Hepatitis B Surface Antigens - blood
Hepatitis B virus - isolation & purification
Hepatitis B virus - physiology
Humans
Immunosuppressive Agents - adverse effects
Kidney Transplantation - physiology
Lamivudine - therapeutic use
Male
Medical sciences
Pharmacology. Drug treatments
Postoperative Complications - virology
Recurrence
Retrospective Studies
Reverse Transcriptase Inhibitors - therapeutic use
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Virus Activation
Asia
China
RNA-directed DNA polymerase
Hepatic disease
Transplantation
Homotransplantation
Kidney
Viral hepatitis B
Surgery
Reverse transcriptase inhibitor
Graft
Antiviral
Complication
Pyrimidine nucleoside
Human
Enzyme
Transferases
Treatment efficiency
Enzyme inhibitor
Lamivudine
Infection
Nucleotidyltransferases
Chemotherapy
Immunosuppression
Treatment
Urinary system
Viral disease
Dideoxynucleoside
Digestive diseases
Nucleosidic analog
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(02)03850-2